Apogem Capital’s Levi Strauss LEVI Stock Holding History

Apogem Capital’s Portfolio LEVI Stock Details LEVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-20,000	Closed	-$326K	–	150
2022 Q2	$326K	Buy	+20,000	New	+$361K	0.29%	105

Other funds holding LEVI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

KAH

Kathryn A. Hall $186M AUM 12.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Apogem Capital's LEVI Position: Q3 2022 in Review

Apogem Capital sold out of Levi Strauss (LEVI) in Q3 2022, closing a stake of 20,000 shares — an estimated $326K sold.

Apogem Capital first reported a position in LEVI in Q2 2022 and held it in 1 quarter. The position peaked at $326K in Q2 2022. 220 funds tracked by Wall St. Rank hold LEVI as of Q3 2022.

Apogem Capital reported no remaining Levi Strauss position as of Q3 2022 after selling out during the quarter.
Apogem Capital sold 20,000 Levi Strauss shares in Q3 2022, an estimated $326K.
Apogem Capital first reported a position in Levi Strauss in Q2 2022 and held it in 1 quarter.
Apogem Capital's Levi Strauss position peaked at $326K in Q2 2022.
220 funds tracked by Wall St. Rank held Levi Strauss as of Q3 2022.

Based on Apogem Capital's 13F filing for Q3 2022, filed 14 Nov 2022.